Fresenius Kabi USA, LLC recalls Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose
Recalled July 29, 2026 · FDA recall D-0727-2026 · Fresenius Kabi USA
Hazard
Presence of Particulate Matter: Hair was found in products · FDA Class II
Units
92,600 vials
Sold at
Nationwide within in the USA
Description
Presence of Particulate Matter: Hair was found in products
Product
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05
Manufacturer(s)
Fresenius Kabi USA, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →